earnings

NASDAQ · AKTX
Akari Therapeutics, Plc
Healthcare · Biotechnology
$8.72
Down-$0.12 (-1.36%)
Updated Oct 4, 2026, 7:27 AM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.22K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.13 – $29.32
- Volume
- 15.26K
- Avg. volume
- 1.09M
Price performance · AKTX
AKTX price history
1M range · 19 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
AKTX closed at $8.72 after 19 trading sessions, down 20.44% for the selected period.
- Last close
- $8.72
- Period change
- -20.44%
- Period low
- $8.72
- Period high
- $11.30
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $9.01 | $9.14 | $8.26 | $8.72 | 15.26K |
| Oct 1, 2026 | $9.35 | $10.00 | $8.55 | $8.84 | 28.6K |
| Sep 30, 2026 | $9.58 | $10.05 | $8.80 | $9.30 | 46.96K |
| Sep 29, 2026 | $9.83 | $10.7474 | $9.55 | $9.72 | 50.67K |
| Sep 28, 2026 | $9.99 | $10.975 | $9.69 | $9.81 | 82.01K |
| Sep 25, 2026 | $10.25 | $10.25 | $9.30 | $9.755 | 71.54K |
| Sep 24, 2026 | $9.90 | $10.10 | $9.565 | $10.06 | 47.39K |
| Sep 23, 2026 | $10.42 | $10.42 | $9.32 | $9.66 | 86.42K |
| Sep 22, 2026 | $9.2359 | $10.10 | $8.53 | $10.05 | 78.48K |
| Sep 21, 2026 | $9.52 | $9.81 | $9.0701 | $9.38 | 18.7K |
| Sep 18, 2026 | $9.63 | $10.125 | $9.16 | $9.16 | 63.65K |
| Sep 17, 2026 | $10.26 | $10.7413 | $9.39 | $9.875 | 126.51K |
| Sep 16, 2026 | $11.00 | $11.00 | $9.78 | $10.12 | 16.37K |
| Sep 15, 2026 | $11.05 | $11.05 | $10.00 | $10.25 | 27.59K |
| Sep 14, 2026 | $11.43 | $11.61 | $10.68 | $11.04 | 39.99K |
| Sep 11, 2026 | $10.51 | $11.50 | $10.51 | $11.30 | 135.28K |
| Sep 10, 2026 | $10.63 | $11.065 | $10.07 | $10.88 | 166.03K |
| Sep 9, 2026 | $10.89 | $12.15 | $10.0187 | $10.57 | 131.07K |
| Sep 8, 2026 | $11.32 | $12.04 | $10.75 | $10.96 | 128.54K |
Latest AKTX news
The latest Smart Investors Daily articles mentioning AKTX.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

